scispace - formally typeset
G

Glenda M. Halliday

Researcher at University of Sydney

Publications -  729
Citations -  65235

Glenda M. Halliday is an academic researcher from University of Sydney. The author has contributed to research in topics: Parkinson's disease & Frontotemporal dementia. The author has an hindex of 111, co-authored 676 publications receiving 53684 citations. Previous affiliations of Glenda M. Halliday include Concord Repatriation General Hospital & Flinders University.

Papers
More filters
Journal ArticleDOI

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

Ian G. McKeith, +45 more
- 27 Dec 2005 - 
TL;DR: The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and pathologic diagnosis of DLB incorporating new information about the core clinical features and suggesting improved methods to assess them as mentioned in this paper.
Journal ArticleDOI

Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

Ian G. McKeith, +95 more
- 04 Jul 2017 - 
TL;DR: The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade.
Journal ArticleDOI

The Sydney Multicenter Study of Parkinson's Disease : The Inevitability of Dementia at 20 years

TL;DR: After 20 years follow-up of newly diagnosed patients with Parkinson's disease (PD), 100 of 136 (74%) have died and 17 people with dementia had postmortems, while others had mixed neuropathology.
Journal ArticleDOI

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

Mike A. Nalls, +248 more
- 01 Dec 2019 - 
TL;DR: These data provide the most comprehensive survey of genetic risk within Parkinson's disease to date, providing a biological context for these risk factors, and showing that a considerable genetic component of this disease remains unidentified.